Conclusion
In summary, both FBHH and NSHPT represent the phenotypic expression of inactivating mutations of the CaSR in most cases, FBHH usually presenting with mild asymptomatic lifelong hypercalcemia and NSHPT with generally more severe, potentially lethal hypercalcemia, which, in cases of homozygous or compound heterozygous CaSR mutations, carries a high morbidity. Additional molecular studies should elucidate the basis for variations in the phenotypic and biochemical abnormalities observed with both FBHH and NSHPT and identify the disease genes on chromosome 19 that can also cause FBHH in rare cases.
Similar content being viewed by others
References
Jackson CE, Boonstra CE. 1966 J Lab Clin Med 68 (abstract): 883.
Foley TP, Harrison HC, Arnaud CD, Harrison HE. 1972 J Pediatr 81:1060–1067.
Marx SJ, Spiegel AM, Brown EM, Aurbach GD, 1977 Am J Med 62:698–706.
Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, Lasker RD. 1981 Medicine (Baltimore) 60:397–412.
Menko FH, Bijvoet OL, Fronen JL, Sandler LM, Adami S, O'Riordan JL, et al. 1983 Q J Med 52 (206): 120–140.
Law WM Jr, Heath H III. 1985 Clinical and pathological studies in 21 families. Ann Intern Med 102(4):511–519.
Lyons TJ, Crookes PF, Postlethwaite W, Sheridan B, Brown RC, Atkinson AB, 1986 Br J Surg 73:188–192.
Toss G, Arnqvist H, Larsson L, Nilsson O, 1989 J Intern Med 225:201–206.
Landon JF. 1932 J Pediatr 1:544–551.
Spiegel AM, Harrison HE, Marx SJ, Brown EM, Aurbach GD. 1977 J Pediatr 90(2):269–272.
Marx SJ, Attie MF, Spiegel AM, Levine MA, Lasker RD, Fox M. 1982 N Engl J Med 306(5):257–264.
Matsuo M, Okia K, Takemine H, Fujita T. 1982 J Dis Child 136(8):728–731.
Lillquist K, Illum N, Jacobsen BB, Lockwood K. 1983 Acad Paediatr Scand 72(4):625–629.
Cooper L, Wertheimer J, Levey R, Brown E, LeBoff M, Wilkinson R, et al. 1986 Pediatrics 78(2):263–268.
Steinman B, Gnehm HE, Rao VH, Kind HP, Prader A, 1984 Helv Paeditr Acta 39(2):171–186.
Page LA, Haddow JE. 1987 J Pediatr 111(5):261–264.
Marx SJ, Fraser D, Rapoport A. 1985 Am J Med 78(1):5–22.
Heath H III. 1989 Endocrinol Metab Clin North Am 18(3):723–740.
Heath DA. 1989 Trends Endocrinol Metab 1:6–9.
Heath H III. 1994 West J Med 160(6):554–561.
Ujihara M, Sato K, Ohashi T, Tomori N, Kasono K, Tsushima T, et al. 1991 Endocrinol Jpn 38(6):689–692.
Heath H III, Leppert MF, Lifton RP, Penniston JT. 1992 J Clin Endocrinol Metab 75(3):846–851.
Menko FH, Bijvoet OL, Khan PM, Nijenhuis LE, Loghem EV, Schreuder I, et al. 1984 Hum Genet 67(4):452–454.
Almahroos GM, Docherty K, Fletcher JA, Webb T, Heath DA, 1987 J Endocrinol 115(1):183–186.
Chou YH, Brown EM, Levi T, et al. 1992 Nat Genet 1:295–300.
Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, et al. 1993 Nature 366:577–580.
Heath H III, Jackson CE, Otterud B, Leppert MF, 1993 Am J Hum Genet 53(1):193–200.
Pearce S, Trump D, Wooding C, Besser G, Chew S, Grant DB, et al. 1995 J Clin Invest 96:2683–2692.
Trump D, Whyte MB, Wooding C, Pang JT, Pearce SH, Kocher DB, et al. 1995 Hum Genet 96(2):183–187.
Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV, 1999 Am J Hum Genet 64(1):189–195.
Pollak MR, Brown EM, Chou YHW, et al. 1993 Cell 75:1297–1303.
Aida K, Koishi S, Inoue M, Nakazato M, Tawanta M, Onaya T, 1995 J Clin Endocrinol Metab 80:2594–2598.
Chou YHW, Pollak MR, Brandi ML, Toss G, Arnqvist H, Atkinson AB, et al. 1995 Am J Hum Genet 56:1075–1079.
Janicic N, Pausova Z, Cole DEC, Hendy GN, 1995 Am J Hum Genet 56:880–886.
Heath H III, Odelberg S, Jackson CE, The BT, Hayward N, Larsson C, et al. 1996 J Clin Endocrinol Metab 814:1312–1317.
Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YH, Riccardi D, et al. 1995 N Engl J Med 333:234–240.
Kolakowski LF. 1994 Receptors Channels 2:1–7.
Carling T, Szabo E, Bai M, Ridefelt P, Wesin G, Gustavsson P, et al. 2000 J Clin Endocrinol Metab 85:2042–2047.
Cole D, Peltekova V, Rubin L, Hawker G, Vieth R, Liew C, et al. 1999 Lancet 353(9147):112–115.
Cole DEC, Vieth R, Trang HM, Wong BYL, Hendy GN, Rubin LA. 2001 Mol Genet Metab 72:168–174.
Bai M, Quinn S, Trivedi S, Kifor O, Pearce SH, Pollak M, et al. 1996 J Biol Chem 271(32):19,537–19,545.
Ward DT, Brown EM, Harris HW, 1998 J Biol Chem 273:14,476–14,483.
Ho C, Conner DA, Pollak MB, Ladd DJ, Kifor O, Warren HB, et al. 1995 Nat Genet 11(4):389–394.
Varrault A, Pena MS, Goldsmith PK, Mithal A, Brown EM, Spiegel AM, 1995 Endocrinology 136(10):4390–4396.
Nemeth EF, Heath H III 1995 Curr Opin Endocrinol Diabetes 2:556–561.
Kifor O, Cantor T, Kifor I, et al. 2000 J Bone Miner Res 15(Suppl 1):1106 (abstract).
Alexandre C, Chappard D, Riffat G, 1983 J Clin Pathol 36(11):1319–1320.
Law WM Jr, Wahner HW, Heath H III. 1984 Mayo Clin Proc 59(12):811–815.
Abugassa S, Nordenstrom J, Jarhult J, 1992 Eur J Surg 158(8):397–402.
Kristiansen JH, Rodbro P, Christiansen C, Johansen J, Jensen JT, 1987 Clin Endocrinol 26:713–716.
Rajala MM, Heath H III 1987 J Clin Endocrinol Metab 65:1039–1041.
Marx SJ, Spiegel AM, Brown EM, Koelhler JO, Gardner DG, Brennan MF, et al. 1978 Am J Med 65(2):235–242.
Firek AF, Kao PC, Heath H III. 1991 J Clin Endocrinol Metab 72: 541–546.
Rajala MM, Klee GG, Heath H III. 1991 J Bone Miner Res 6:117–124.
Auwerx J, Demedts M, Bouillon R, 1984 Acta Endocrinol 106:215–218.
Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Health H III. 1993 J Clin Endocrinol Metab 76:715–720.
El-Hajj Fuleihan G, Heath H III. 2001 In: The Parathyroids: Basic and Clinical Concepts. Bilezikian JP, Marcus R, Levine MA, eds. Academic, San Diego, CA.
Thorgeirsson U, Costa J, Marx SJ. 1981 Hum Pathol 12:229–237.
Law WM Jr, Carney JA, Heath H III. 1984 Am J Med 76:1021–1026.
Attie MA, Gill JR Jr, Stock JL, Spiegel AM, Downs RW Jr, Levine MA, et al. 1983 J Clin Invest 72:667–676.
Davies M, Adams PH, Lump GA, Berry JL, Leverage N. 1984 Acta Endocrinol 106:499–504.
Marx SJ, Attie MF, Stock JL, Speigel AM, Levine MA. 1981 J Clin Endocrinol Metab 52:736–740.
Corbeel L, Casaer P, Malvaux P, Lormans J, Bourgeois N. 1968 Arch Franç Péd 25:879–891.
Fujimoto Y, Hazama H, Oku K. 1990 Surgery 108:933–938.
Wilkinson H, James J. 1993 Arch Dis Child 69:319–321.
Harris S, D'Ercole A. 1989 Pediatrics 83:53–56.
Pollak MR, Chou YHW, Marx SJ, Steinmann B, Cole DEC, Brandl ML, et al. 1994 J Clin Invest 93:1108–1112.
Koboyashi M, Tanaka H, Tsuzuki K, Tsuyukim M, Igaki H, Ichinose Y, et al. 1997 J Clin Endocrinol Metab 82:2716–2719.
Bai M, Pearce SH, Kifor O, Trivedi S, Stauffer UG, Thakker RV, et al. 1997 J Clin Invest 99:88–96.
Lutz P, Kane O, Pfersdorff A, Seiller F, Sauvage P, Ievy JM, 1986 Acta Pediatr Scand 75:179–182.
Wada M, Nagano N, Nemeth EF, 1999 Curr Opin Nephrol Hypertens 8(4):429–433.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuleihan, G.EH., Brown, E.M. Familial benign hypocalciuric hypercalcemia and neonatal hyperparathyroidism. Clinic Rev Bone Miner Metab 1, 77–84 (2002). https://doi.org/10.1385/BMM:1:1:77
Issue Date:
DOI: https://doi.org/10.1385/BMM:1:1:77